Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,677 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Lipidomic profiling of plasma from patients with multiple myeloma receiving bortezomib: an exploratory biomarker study of JCOG1105 (JCOG1105A1).
Ri M, Iida S, Saito K, Saito Y, Maruyama D, Asano A, Fukuhara S, Tsujimura H, Miyazaki K, Ota S, Fukuhara N, Negoro E, Kuroda J, Yoshida S, Ohtsuka E, Norifumi T, Tabayashi T, Takayama N, Saito T, Suzuki Y, Harada Y, Mizuno I, Yoshida I, Maruta M, Takamatsu Y, Katsuya H, Yoshimitsu M, Minami Y, Kanato K, Munakata W, Nagai H. Ri M, et al. Among authors: miyazaki k. Cancer Chemother Pharmacol. 2025 Jan 24;95(1):29. doi: 10.1007/s00280-025-04752-1. Cancer Chemother Pharmacol. 2025. PMID: 39853402 Clinical Trial.
Clinical significance of the estimation of pulmonary-right ventricular uncoupling in patients with transthyretin amyloid cardiomyopathy.
Usuku H, Yamamoto E, Miyazaki K, Higashi R, Nozuhara A, Oike F, Kuyama N, Tabata N, Ishii M, Hanatani S, Hoshiyama T, Kanazawa H, Sueta D, Arima Y, Oda S, Kawano H, Matsuzawa Y, Izumiya Y, Ueda M, Tanaka Y, Tsujita K. Usuku H, et al. Among authors: miyazaki k. Eur Heart J Imaging Methods Pract. 2025 Jan 17;3(1):qyae113. doi: 10.1093/ehjimp/qyae113. eCollection 2025 Jan. Eur Heart J Imaging Methods Pract. 2025. PMID: 39831277 Free PMC article.
Effect of fezolinetant on patient-reported quality-of-life outcomes: Data from a phase 3b study (DAYLIGHT) of the treatment of moderate to severe vasomotor symptoms associated with menopause in women considered unsuitable for hormone therapy.
Shapiro C M M, Wu X, Wang X, Miyazaki K, Morga A, Nappi RE, Stute P, Martins K, Schaudig K. Shapiro C M M, et al. Among authors: miyazaki k. Maturitas. 2025 Feb;193:108159. doi: 10.1016/j.maturitas.2024.108159. Epub 2024 Nov 26. Maturitas. 2025. PMID: 39809112 Free article. Clinical Trial.
2,677 results